Acrux dumped on fears of tighter testosterone drug controls

September 18, 2014 5:16 AM

12 0

The US government has been asked to tighten labelling of testosterone drugs following a sharp rise in sales and concerns of possible adverse effects from prescribing the drugs to some patients.

Speculation of tougher controls over testosterone drugs saw the sharemarket value of Acrux slashed by a quarter early on Thursday, before the shares were suspended from trading.

Read more

To category page